RMACT's IVF Opportunity Plan is the only all-inclusive IVF treatment plan in the Tri-State Connecticut Region that includes medication. In many cases, patients who want to have a baby do so with In vitro fertilization (IVF). During an IVF cycle, women are treated with medications to stimulate the development of multiple ovarian follicles to produce eggs for fertilization. Eggs are then retrieved from the woman and are combined with sperm in a laboratory. One or more embryos are then transferred into the woman’s uterus to achieve a pregnancy.
To help make this option available to as many patients as possible, RMA of Connecticut offers The IVF Opportunity Plan. This unique payment plan is available exclusively to RMACT patients who do not have insurance coverage for their fertility treatments.
RMACT’s IVF with PGS Opportunity Plan is the only all-inclusive IVF treatment plan that includes embryo screening.
When IVF is required for a patient to conceive, RMACT has the ability to screen each embryo for chromosomal abnormalities before the embryo is transferred back into the uterus. The purpose of Preimplantation Genetic Screening (PGS) is to identify and only transfer embryos that do not have abnormalities in their number of chromosomes. Screening embryos in advance can help achieve higher implantation rates and fewer pregnancy losses.
Patients who could benefit from PGS include: women 35 or older, those with multiple-failed IVF cycles and patients with recurrent miscarriages. This unique payment plan is available exclusively to RMACT patients who do not have insurance coverage for their fertility treatments.
To find out if either of these treatment plans are right for you, please contact us here.